The novel treatment of this peptide represents a major advance in the care of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide308522.oblogation.com/40814688/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment